LifeSteps Financial’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

LifeSteps Financial’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-870	Closed	-$122	–	439
2024 Q1	$122	Buy	+870	New	+$171	﹤0.01%	433

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

LifeSteps Financial's GRTX Position: Q2 2024 in Review

LifeSteps Financial sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 870 shares — an estimated $122 sold.

LifeSteps Financial first reported a position in GRTX in Q1 2024 and held it in 1 quarter. The position peaked at $122 in Q1 2024. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

LifeSteps Financial reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
LifeSteps Financial sold 870 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $122.
LifeSteps Financial first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
LifeSteps Financial's Galera Therapeutics, Inc. Common Stock position peaked at $122 in Q1 2024.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on LifeSteps Financial's 13F filing for Q2 2024, filed 17 Jul 2024.